insights_auto
Pse është rritur TAK 2,13%?
Zhytu më thellëchevron_right
TAK:NYSE
Takeda Pharmaceutical Co Ltd
18,92Â US$
arrow_upward
+2,13%(+0,40) 1D
14 tet, 12:21:50 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TAK...
Hap
18,63Â US$
I lartë
18,95Â US$
I ulët
18,57Â US$
Kapitalizimi i tregut
61,52Â mld
Vëllimi mesatar
2,42Â mln
Vëllimi
1,49Â mln
Dividendi
3,33%
Dividendi tremujor
0,16Â US$
Data e ndërprerjes së dividendit
29 sht 2026
Maksimumi 52-javor
19,10Â US$
Minimumi 52-javor
12,99Â US$
Fitimet për aksion
-0,33Â US$
Beta
-0,06
Aksionet në qarkullim
3,20Â mld
Numri i punonjësve
47 mijë
Hap
18,63Â US$
I lartë
18,95Â US$
I ulët
18,57Â US$
Kapitalizimi i tregut
61,52Â mld
Vëllimi mesatar
2,42Â mln
Vëllimi
1,49Â mln
Dividendi
3,33%
Dividendi tremujor
0,16Â US$
Data e ndërprerjes së dividendit
29 sht 2026
Maksimumi 52-javor
19,10Â US$
Minimumi 52-javor
12,99Â US$
Fitimet për aksion
-0,33Â US$
Beta
-0,06
Aksionet në qarkullim
3,20Â mld
Numri i punonjësve
47 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
29 minuta më parë
Takeda Pharmaceutical stock trades at 52.50 times earnings
Investing.com Canada
·
3 orë më parë
Takeda presents detailed results from TAK-881 trial at ESID By Investing.com
Profili
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Rreth Takeda Pharmaceutical Co Ltd
Drejtori ekzekutivChristophe Weber | Christophe Weber
Punonjësit47 mijë
Themeluar më12 qer 1781
Selia-
Sektori-
Uebsajtitakeda.com